CytoSorbents Q2 EPS $(0.14) Misses $(0.11) Estimate, Sales $9.42M Miss $11.03M Estimate
Portfolio Pulse from mahesh@benzinga.com
CytoSorbents (NASDAQ:CTSO) reported Q2 losses of $(0.14) per share, missing the analyst consensus estimate of $(0.11) by 27.27%. The company also reported quarterly sales of $9.42 million, missing the analyst consensus estimate of $11.03 million by 14.59%. However, both losses and sales showed an increase compared to the same period last year.
August 04, 2023 | 10:27 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CytoSorbents reported Q2 losses and sales that missed analyst estimates, but showed an increase compared to the same period last year.
CytoSorbents' Q2 results missed analyst estimates, which could negatively impact the stock price in the short term. However, the year-on-year improvement in losses and sales might mitigate this impact to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100